LUDG Stock Overview
Ludwig Enterprises, Inc. operates as a medical technology holding company.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Ludwig Enterprises, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.30 |
| 52 Week High | US$0.52 |
| 52 Week Low | US$0.062 |
| Beta | 2.38 |
| 1 Month Change | 3.45% |
| 3 Month Change | 214.14% |
| 1 Year Change | 114.29% |
| 3 Year Change | 328.57% |
| 5 Year Change | 1,100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| LUDG | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 30.4% | -4.2% | -3.7% |
| 1Y | 114.3% | -2.0% | 20.5% |
Return vs Industry: LUDG exceeded the US Biotechs industry which returned -1.7% over the past year.
Return vs Market: LUDG exceeded the US Market which returned 20.2% over the past year.
Price Volatility
| LUDG volatility | |
|---|---|
| LUDG Average Weekly Movement | 55.4% |
| Biotechs Industry Average Movement | 11.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LUDG's share price has been volatile over the past 3 months.
Volatility Over Time: LUDG's weekly volatility has increased from 45% to 55% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 1 | Marvin Hausman | www.ludwigent.com |
Ludwig Enterprises, Inc. operates as a medical technology holding company. It engages in the developing of messenger ribonucleic acid (mRNA) genetic testing kits to treat inflammatory genetic markers associated with chronic diseases. The company was founded in 2006 and is based in Sparks, Nevada.
Ludwig Enterprises, Inc. Fundamentals Summary
| LUDG fundamental statistics | |
|---|---|
| Market cap | US$47.71m |
| Earnings (TTM) | -US$2.46m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-19.4x
P/E RatioIs LUDG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LUDG income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.46m |
| Earnings | -US$2.46m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.015 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -93.7% |
How did LUDG perform over the long term?
See historical performance and comparison